← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Retrovirox, Inc.
San Diego, CA
$4,981,431
Total funding
5
Grants
Funding over time
peak $1.2M · FY2009–17$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,981,431 · 5
By mechanism
R44$2,999,994 · 1
R43$1,981,437 · 4
Investigators at Retrovirox, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
An immune-based approach for HIV eradication$1,226,363
R44 · FY2016 · AI
An immune-based approach for HIV eradication$1,108,021
R44 · FY2015 · AI
An immune-based approach for HIV eradication$665,610
R44 · FY2017 · AI
Small-molecule inhibitors of HIV-induced receptor downmodulation$356,280
R43 · FY2010 · AI
Novel Screen to Identify Arenavirus Inhibitors$300,000
R43 · FY2014 · AI
Inhibitors of HIV-induced downregulation of HLA class I$300,000
R43 · FY2012 · AI
Novel Screen to Identify Arenavirus Inhibitors$299,739
R43 · FY2013 · AI
Small-molecule inhibitors of HIV-induced receptor downmodulation$296,875
R43 · FY2009 · AI
Targeting HIV-1 Envelope glycoprotein incorporation$218,374
R43 · FY2009 · AI
Inhibitors of HIV-induced downregulation of HLA class I$210,169
R43 · FY2013 · AI